Runs a value-oriented long/short equity shop with a concentration in healthcare and consumer franchises, pursuing concentrated public-equity positions and occasional activist engagement to influence corporate strategy and board composition. The investment approach blends fundamental research with industry specialization to identify durable cash-flow compounders and restructuring candidates across the U.S. market. Larry Robbins founded and serves as CEO of his flagship firm, which manages institutional capital for pensions, endowments and family offices while retaining a high-conviction portfolio construction style and a bias toward deep sector expertise that informs both stock selection and risk management.
Runs a value-oriented long/short equity shop with a concentration in healthcare and consumer franchises, pursuing concentrated public-equity positions and occasional activist engagement to influence corporate strategy and board composition. The investment approach blends fundamental research with industry specialization to identify durable cash-flow compounders and restructuring candidates across the U.S. market. Larry Robbins founded and serves as CEO of his flagship firm, which manages institutional capital for pensions, endowments and family offices while retaining a high-conviction portfolio construction style and a bias toward deep sector expertise that informs both stock selection and risk management.
Value-driven long/short equity investor with concentrated, high-conviction portfolios focused on healthcare and consumer franchises. Emphasizes deep fundamental research and sector specialization to uncover durable cash-flow compounders, turnaround and restructuring opportunities, and selective activist initiatives to reshape corporate strategy and governance. Capital allocation favors concentrated positions with active risk controls, multi-year time horizons, and opportunistic use of leverage and hedges to protect downside while maximizing asymmetric upside for institutional mandates.
Value-driven long/short equity investor with concentrated, high-conviction portfolios focused on healthcare and consumer franchises. Emphasizes deep fundamental research and sector specialization to uncover durable cash-flow compounders, turnaround and restructuring opportunities, and selective activist initiatives to reshape corporate strategy and governance. Capital allocation favors concentrated positions with active risk controls, multi-year time horizons, and opportunistic use of leverage and hedges to protect downside while maximizing asymmetric upside for institutional mandates.
| Trades 5039 | Longs Won 2619/5039 51% | Profit Factor 2.25 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $22.12M |
| Average Win $11M | Best Trade (Mar 31) $588.06M | Sharpe Ratio -41.18 |
| Average Loss -$5.3M | Worst Trade (Mar 31) -$162.06M | Z-Score -16.51 (100%) |
| Commissions $0 | Avg. Trade Length 1y 1m 4w | Expectancy $3.17M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | 0.14% |
| Consecutive Losing Trades | 907 | 817 | 726 | 635 | 544 | 454 | 363 | 272 | 181 | 91 |